Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol for blood loss control during abdominal myomectomy
IRCT20250716066511N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Hemoglobin level change, Intraoperative blood loss volume and 4 more. Started Jul 2025; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20250716066511N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250716066511N1.